Absence of CTL responses to early viral antigens facilitates viral persistence

Anita Schildknecht1, Sarah Welti, Markus B Geuking

  • 1Institute of Experimental Immunology, University Hospital Zurich, Zurich, Switzerland.

Insights

CD8+ T cells targeting early viral antigens are key for controlling lymphocytic choriomeningitis virus (LCMV) infections. The timing of antigen presentation significantly impacts the effectiveness of antiviral immunity and vaccine development.

Area of Science:

  • Immunology
  • Virology
  • Vaccinology

Background:

  • CD8+ T cells are essential for managing viral infections.
  • The timing of antigen presentation influences the T cell response, potentially leading to T cell exhaustion.
  • Lymphocytic choriomeningitis virus (LCMV) serves as a model for studying viral immune responses.

Purpose of the Study:

  • To investigate the role of CD8+ T cell responses to early versus late viral antigens in controlling LCMV infection.
  • To determine if T cell tolerance to early viral epitopes compromises viral control.

Main Methods:

  • Utilized a mouse model of lymphocytic choriomeningitis virus (LCMV) infection.
  • Assessed the impact of antigen presentation kinetics on CD8+ T cell immunodominance and exhaustion.
  • Evaluated viral control in mice tolerant to nucleoprotein (NP)-derived T cell epitopes.

Main Results:

  • CD8+ T cells responding to early LCMV nucleoprotein (NP)-derived epitopes are more critical for viral control than those targeting later glycoprotein-derived epitopes.
  • Mice tolerant to NP-derived epitopes showed significantly impaired control of larger LCMV inocula.
  • The kinetics of viral antigen presentation directly impact the efficacy of antiviral CD8+ T cell immunity.

Conclusions:

  • Early viral antigens presented by CD8+ T cells play a crucial role in acute viral control.
  • Vaccine strategies should consider the kinetics of antigen presentation to optimize antiviral immunity.

Related Concept Videos

Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Immunological Memory01:23

Immunological Memory

Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature is...
Vaccinations01:51

Vaccinations

Overview
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview